THE OVARIAN RESERVE FOR WOMEN OF REPRODUCTIVE RETURN WITH POLYCYSTIC OVARY SYNDROME IN DEPENDENCE ON THE PHENOTYPE
Main Article Content
Abstract
Objective – to determine the ovarian reserve in women of reproductive age with PCOS, depending on the phenotype.
Materials and methods. 60 women of reproductive age with and without polycystic ovary syndrome were included in the study. All patients underwent general clinical, gynecological, instrumental assessment. The statistical analysis was performed using the commercially available statistical software package.
Results. Statistically significant differences in the main parameters of the ovarian reserve in reproductive age women with polycystic ovary syndrome depending on the phenotype in comparison with women without polycystic ovary syndrome have been determined. Women with a basic (classical) and anovulatory phenotypes had elevated AMH levels, whereas women with ovulatory and non-androgenic phenotypes – within reference range. The volume of each ovary and the number of antral follicles were higher in women with polycystic ovary syndrome with primary (classical), ovulatory and non-androgenic phenotypes. These indicators were slightly different in women with anovulatory phenotype.
Conclusion. The study of ovarian reserve in reproductive age patients with polycystic ovary syndrome will allow to more accurately determine the reproductive potential of each specific woman and influence the choice of treatment tactics. The results demonstrate the need to include the definition of AMH in women of reproductive age with polycystic ovary syndrome as an additional diagnostic criterion for the delivery of the diagnosis and determination of further management tactics.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Dedova II, Melnichenko GA. Polycystic ovary syndrome. A guide for doctors. 2007. P. 66-70. Russian (Дедова И.И., Мельниченко Г.А. Синдром поликистозных яичников. Руководство для врачей. 2007. С. 66-70)
Tumilovich LG, Gevorkyan MA. Handbook of the gynecologist-endocrinologist. M., 2014. P. 111-117. Russian (Тумилович Л.Г., Геворкян М.А. Справочник гинеколога-эндокринолога. М., 2014. С. 111-117)
Azziz R. Controversy in clinical endocrinology diagnosis jf polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006; 91(3): 781-785
Shestakova IG, Ryabinkina ТS, Ed. VE Radzinsky. PCOS: a new look at the problem. Variety of symptoms, differential diagnosis and treatment of PCOS: Newsletter. M.: Editorial Board of the Journal StatusPraesens, 2015. P. 4-8. Russian (Шестакова И.Г., Рябинкина Т.С., под ред. В.Е. Радзинского. СПКЯ: новый взгляд на проблему. Многообразие симптомов, дифференциальная диагностика и лечение СПКЯ: Информационный бюллетень. М.: Редакция журнала StatusPraesens, 2015. С. 4-8)
Fauser BC, Tarlatzis BC, Rebar RW et al. Consensus on womens health aspects of polycystic ovary syndrome: the Amsterdam ESHRE/ASRM – Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jun; 97(1): 28-38
Andreeva EN, Hamoshina MB. PCOS: from the revision of the views to the new therapeutic strategies. Modern scientific data and clinical recommendations of the Ministry of Health of the Russian Federation in 2015: Information newsletter. Editorial office of the Journal StatusPraesens, 2016. 28 p. Russian (Андреева Е.Н., Хамошина М.Б. СПКЯ: от пересмотра представлений к новым терапевтическим стратегиям. Современные научные данные и клинические рекомендации МЗ РФ 2015года: Информационный бюллетень. М.: Редакция журнала StatusPraesens, 2016. 28 с.)
Polycystic ovary syndrome. The official statement of the European Society of Endocrinology (EUROPEAN SOCIETY OF ENDOCRINOLOGY, ESE). GERARD CONWAY Department of Endocrinology, University College London Hospital, London, UK DIDIER DEWAILLY Department of Endocrine Gynecology and Reproductive Medicine, Lille Clinical Center, Countess Jeanne Flandres Hospital, Lille, France EVANTHIA DIAMANTIKANDARAKIS Endocrine Department of the Third Medical Chair, Athens University Medical School, Athens, Greece and other participants of the Special Group on PCOS of the European Society of Endocrinology. – P. 1-13
PCOS in reproductive age (modern approaches to diagnosis and treatment): Clinical protocol. М., 2015. Russian (СПКЯ в репродуктивном возрасте (современные подходы к диагностике и лечению): Клинический протокол. М., 2015)
Polycystic ovary syndrome: Clinical recommendations. M., 2016. Russian (Синдром поликистозных яичников: Клинические рекомендации. М., 2016)
Ovarian reserve and fertility: the challenges of the 21st century. Rational approach to preserving the reproductive reserve as a pledge of fertility and conscious procreation: Information letter /Ed. VE Radzinsky. M.: Editorial Board of the Journal StatusPraesens, 2015. P. 2-18. Russian (Овариальный резерв и фертильность: сложности XXI века. Рациональный подход к сохранению репродуктивного резерва как залог фертильности и осознанного деторождения: Информационное письмо /Под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2015. С. 2-18)
Nazarenko TA, Mishieva NG.. Infertility and age. Ways to solve the problem. M., 2014. P. 75-95. Russian (Назаренко Т.А., Мишиева Н.Г. Бесплодие и возраст. Пути решения проблемы. М., 2014. С. 75-95)
Van Houten EL, Themmen AP, Visser JA. AntiMullerian hormone (AMH) regulator and marker for ovarian function. Ann. Endocrinol. 2010; 71(3)
Nazarenko TA. Polycystic ovary syndrome. Modern approaches to the diagnosis and treatment of infertility. M., 2008. P. 19-48. Russian (Назаренко Т.А. Синдром поликистозных яичников. Современные подходы к диагностике и лечению бесплодия. М., 2008. С. 19-48)